Strategen Bio: Novel tissue oxygen sensors to enable personalized care

Gregory Ekchian
CEO & Co-founder, Strategen Bio

SENSE.nano 2021
Tuesday, October 26
Session:  Startups
12:55 PM - 1:00 PM EDT

Abstract
TBD
 

Biography
Greg Ekchian, PhD, is an entrepreneur, engineer, and innovator. He has spent his career at the interface of academic research and life science start-ups. Greg is currently the co-founder and CEO of Stratagen Bio, where he is developing a suite of novel tissue oxygen sensors to personalize and customize treatments across a wide range of clinical indications. He was previously awarded the Blavatnik Fellowship in Life Science Entrepreneurship at Harvard Business School and the Kavanaugh Translational Innovation Fellowship at the Massachusetts Institute of Technology. Greg was also named to MIT Technology Review’s 35 Innovators Under 35 in 2020. He holds a BS in Biomedical Engineering from Boston University and an MEng and PhD in Materials Science and Engineering from the Massachusetts Institute of Technology.